Global Joint Pain Injections Market Growth 2025-2031

December 2025 | 90 pages | ID: GF3F8A66DADEN
LP Information

Abstracts

The global Joint Pain Injections market size is predicted to grow from US$ 3200 million in 2025 to US$ 4334 million in 2031; it is expected to grow at a CAGR of 5.2% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Based on injection type, the global joint pain injections market has been segmented into corticosteroid injections, hyaluronic acid injections, and others. In terms of joint type, the global joint pain injections market has been divided into knee & ankle, hip joint, shoulder & elbow, facet joints of the spine, and others. Based on distribution channel, the market has been segregated into hospital pharmacies, retail pharmacies, and online pharmacies.

United States market for Joint Pain Injections is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Joint Pain Injections is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Joint Pain Injections is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Joint Pain Injections players cover Allergan, Pfizer, Sanofi, Anika Therapeutics, Ferring, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Joint Pain Injections Industry Forecast” looks at past sales and reviews total world Joint Pain Injections sales in 2024, providing a comprehensive analysis by region and market sector of projected Joint Pain Injections sales for 2025 through 2031. With Joint Pain Injections sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Joint Pain Injections industry.

This Insight Report provides a comprehensive analysis of the global Joint Pain Injections landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Joint Pain Injections portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Joint Pain Injections market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Joint Pain Injections and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Joint Pain Injections.

This report presents a comprehensive overview, market shares, and growth opportunities of Joint Pain Injections market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Corticosteroid Injections
• Hyaluronic Acid Injections
• Others

Segmentation by Application:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Allergan
• Pfizer
• Sanofi
• Anika Therapeutics
• Ferring
• Bioventus
• Flexion Therapeutics
• Zimmer Biomet Holdings
• SEIKAGAKU CORPORATION
• Chugai Pharmaceutical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Joint Pain Injections market?

What factors are driving Joint Pain Injections market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Joint Pain Injections market opportunities vary by end market size?

How does Joint Pain Injections break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Joint Pain Injections Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Joint Pain Injections by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Joint Pain Injections by Country/Region, 2020, 2024 & 2031
2.2 Joint Pain Injections Segment by Type
  2.2.1 Corticosteroid Injections
  2.2.2 Hyaluronic Acid Injections
  2.2.3 Others
2.3 Joint Pain Injections Sales by Type
  2.3.1 Global Joint Pain Injections Sales Market Share by Type (2020-2025)
  2.3.2 Global Joint Pain Injections Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Joint Pain Injections Sale Price by Type (2020-2025)
2.4 Joint Pain Injections Segment by Application
  2.4.1 Hospital Pharmacies
  2.4.2 Retail Pharmacies
  2.4.3 Online Pharmacies
2.5 Joint Pain Injections Sales by Application
  2.5.1 Global Joint Pain Injections Sale Market Share by Application (2020-2025)
  2.5.2 Global Joint Pain Injections Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Joint Pain Injections Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Joint Pain Injections Breakdown Data by Company
  3.1.1 Global Joint Pain Injections Annual Sales by Company (2020-2025)
  3.1.2 Global Joint Pain Injections Sales Market Share by Company (2020-2025)
3.2 Global Joint Pain Injections Annual Revenue by Company (2020-2025)
  3.2.1 Global Joint Pain Injections Revenue by Company (2020-2025)
  3.2.2 Global Joint Pain Injections Revenue Market Share by Company (2020-2025)
3.3 Global Joint Pain Injections Sale Price by Company
3.4 Key Manufacturers Joint Pain Injections Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Joint Pain Injections Product Location Distribution
  3.4.2 Players Joint Pain Injections Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR JOINT PAIN INJECTIONS BY GEOGRAPHIC REGION

4.1 World Historic Joint Pain Injections Market Size by Geographic Region (2020-2025)
  4.1.1 Global Joint Pain Injections Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Joint Pain Injections Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Joint Pain Injections Market Size by Country/Region (2020-2025)
  4.2.1 Global Joint Pain Injections Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Joint Pain Injections Annual Revenue by Country/Region (2020-2025)
4.3 Americas Joint Pain Injections Sales Growth
4.4 APAC Joint Pain Injections Sales Growth
4.5 Europe Joint Pain Injections Sales Growth
4.6 Middle East & Africa Joint Pain Injections Sales Growth

5 AMERICAS

5.1 Americas Joint Pain Injections Sales by Country
  5.1.1 Americas Joint Pain Injections Sales by Country (2020-2025)
  5.1.2 Americas Joint Pain Injections Revenue by Country (2020-2025)
5.2 Americas Joint Pain Injections Sales by Type (2020-2025)
5.3 Americas Joint Pain Injections Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Joint Pain Injections Sales by Region
  6.1.1 APAC Joint Pain Injections Sales by Region (2020-2025)
  6.1.2 APAC Joint Pain Injections Revenue by Region (2020-2025)
6.2 APAC Joint Pain Injections Sales by Type (2020-2025)
6.3 APAC Joint Pain Injections Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Joint Pain Injections by Country
  7.1.1 Europe Joint Pain Injections Sales by Country (2020-2025)
  7.1.2 Europe Joint Pain Injections Revenue by Country (2020-2025)
7.2 Europe Joint Pain Injections Sales by Type (2020-2025)
7.3 Europe Joint Pain Injections Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Joint Pain Injections by Country
  8.1.1 Middle East & Africa Joint Pain Injections Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Joint Pain Injections Revenue by Country (2020-2025)
8.2 Middle East & Africa Joint Pain Injections Sales by Type (2020-2025)
8.3 Middle East & Africa Joint Pain Injections Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Joint Pain Injections
10.3 Manufacturing Process Analysis of Joint Pain Injections
10.4 Industry Chain Structure of Joint Pain Injections

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Joint Pain Injections Distributors
11.3 Joint Pain Injections Customer

12 WORLD FORECAST REVIEW FOR JOINT PAIN INJECTIONS BY GEOGRAPHIC REGION

12.1 Global Joint Pain Injections Market Size Forecast by Region
  12.1.1 Global Joint Pain Injections Forecast by Region (2026-2031)
  12.1.2 Global Joint Pain Injections Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Joint Pain Injections Forecast by Type (2026-2031)
12.7 Global Joint Pain Injections Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Allergan
  13.1.1 Allergan Company Information
  13.1.2 Allergan Joint Pain Injections Product Portfolios and Specifications
  13.1.3 Allergan Joint Pain Injections Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Allergan Main Business Overview
  13.1.5 Allergan Latest Developments
13.2 Pfizer
  13.2.1 Pfizer Company Information
  13.2.2 Pfizer Joint Pain Injections Product Portfolios and Specifications
  13.2.3 Pfizer Joint Pain Injections Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Pfizer Main Business Overview
  13.2.5 Pfizer Latest Developments
13.3 Sanofi
  13.3.1 Sanofi Company Information
  13.3.2 Sanofi Joint Pain Injections Product Portfolios and Specifications
  13.3.3 Sanofi Joint Pain Injections Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Sanofi Main Business Overview
  13.3.5 Sanofi Latest Developments
13.4 Anika Therapeutics
  13.4.1 Anika Therapeutics Company Information
  13.4.2 Anika Therapeutics Joint Pain Injections Product Portfolios and Specifications
  13.4.3 Anika Therapeutics Joint Pain Injections Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Anika Therapeutics Main Business Overview
  13.4.5 Anika Therapeutics Latest Developments
13.5 Ferring
  13.5.1 Ferring Company Information
  13.5.2 Ferring Joint Pain Injections Product Portfolios and Specifications
  13.5.3 Ferring Joint Pain Injections Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Ferring Main Business Overview
  13.5.5 Ferring Latest Developments
13.6 Bioventus
  13.6.1 Bioventus Company Information
  13.6.2 Bioventus Joint Pain Injections Product Portfolios and Specifications
  13.6.3 Bioventus Joint Pain Injections Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Bioventus Main Business Overview
  13.6.5 Bioventus Latest Developments
13.7 Flexion Therapeutics
  13.7.1 Flexion Therapeutics Company Information
  13.7.2 Flexion Therapeutics Joint Pain Injections Product Portfolios and Specifications
  13.7.3 Flexion Therapeutics Joint Pain Injections Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Flexion Therapeutics Main Business Overview
  13.7.5 Flexion Therapeutics Latest Developments
13.8 Zimmer Biomet Holdings
  13.8.1 Zimmer Biomet Holdings Company Information
  13.8.2 Zimmer Biomet Holdings Joint Pain Injections Product Portfolios and Specifications
  13.8.3 Zimmer Biomet Holdings Joint Pain Injections Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 Zimmer Biomet Holdings Main Business Overview
  13.8.5 Zimmer Biomet Holdings Latest Developments
13.9 SEIKAGAKU CORPORATION
  13.9.1 SEIKAGAKU CORPORATION Company Information
  13.9.2 SEIKAGAKU CORPORATION Joint Pain Injections Product Portfolios and Specifications
  13.9.3 SEIKAGAKU CORPORATION Joint Pain Injections Sales, Revenue, Price and Gross Margin (2020-2025)
  13.9.4 SEIKAGAKU CORPORATION Main Business Overview
  13.9.5 SEIKAGAKU CORPORATION Latest Developments
13.10 Chugai Pharmaceutical
  13.10.1 Chugai Pharmaceutical Company Information
  13.10.2 Chugai Pharmaceutical Joint Pain Injections Product Portfolios and Specifications
  13.10.3 Chugai Pharmaceutical Joint Pain Injections Sales, Revenue, Price and Gross Margin (2020-2025)
  13.10.4 Chugai Pharmaceutical Main Business Overview
  13.10.5 Chugai Pharmaceutical Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Joint Pain Injections Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Joint Pain Injections Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Corticosteroid Injections
Table 4. Major Players of Hyaluronic Acid Injections
Table 5. Major Players of Others
Table 6. Global Joint Pain Injections Sales by Type (2020-2025) & (K Units)
Table 7. Global Joint Pain Injections Sales Market Share by Type (2020-2025)
Table 8. Global Joint Pain Injections Revenue by Type (2020-2025) & ($ million)
Table 9. Global Joint Pain Injections Revenue Market Share by Type (2020-2025)
Table 10. Global Joint Pain Injections Sale Price by Type (2020-2025) & (USD/Unit)
Table 11. Global Joint Pain Injections Sale by Application (2020-2025) & (K Units)
Table 12. Global Joint Pain Injections Sale Market Share by Application (2020-2025)
Table 13. Global Joint Pain Injections Revenue by Application (2020-2025) & ($ million)
Table 14. Global Joint Pain Injections Revenue Market Share by Application (2020-2025)
Table 15. Global Joint Pain Injections Sale Price by Application (2020-2025) & (USD/Unit)
Table 16. Global Joint Pain Injections Sales by Company (2020-2025) & (K Units)
Table 17. Global Joint Pain Injections Sales Market Share by Company (2020-2025)
Table 18. Global Joint Pain Injections Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Joint Pain Injections Revenue Market Share by Company (2020-2025)
Table 20. Global Joint Pain Injections Sale Price by Company (2020-2025) & (USD/Unit)
Table 21. Key Manufacturers Joint Pain Injections Producing Area Distribution and Sales Area
Table 22. Players Joint Pain Injections Products Offered
Table 23. Joint Pain Injections Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Joint Pain Injections Sales by Geographic Region (2020-2025) & (K Units)
Table 27. Global Joint Pain Injections Sales Market Share Geographic Region (2020-2025)
Table 28. Global Joint Pain Injections Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Joint Pain Injections Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Joint Pain Injections Sales by Country/Region (2020-2025) & (K Units)
Table 31. Global Joint Pain Injections Sales Market Share by Country/Region (2020-2025)
Table 32. Global Joint Pain Injections Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Joint Pain Injections Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Joint Pain Injections Sales by Country (2020-2025) & (K Units)
Table 35. Americas Joint Pain Injections Sales Market Share by Country (2020-2025)
Table 36. Americas Joint Pain Injections Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Joint Pain Injections Sales by Type (2020-2025) & (K Units)
Table 38. Americas Joint Pain Injections Sales by Application (2020-2025) & (K Units)
Table 39. APAC Joint Pain Injections Sales by Region (2020-2025) & (K Units)
Table 40. APAC Joint Pain Injections Sales Market Share by Region (2020-2025)
Table 41. APAC Joint Pain Injections Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Joint Pain Injections Sales by Type (2020-2025) & (K Units)
Table 43. APAC Joint Pain Injections Sales by Application (2020-2025) & (K Units)
Table 44. Europe Joint Pain Injections Sales by Country (2020-2025) & (K Units)
Table 45. Europe Joint Pain Injections Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Joint Pain Injections Sales by Type (2020-2025) & (K Units)
Table 47. Europe Joint Pain Injections Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & Africa Joint Pain Injections Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & Africa Joint Pain Injections Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Joint Pain Injections Sales by Type (2020-2025) & (K Units)
Table 51. Middle East & Africa Joint Pain Injections Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Joint Pain Injections
Table 53. Key Market Challenges & Risks of Joint Pain Injections
Table 54. Key Industry Trends of Joint Pain Injections
Table 55. Joint Pain Injections Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Joint Pain Injections Distributors List
Table 58. Joint Pain Injections Customer List
Table 59. Global Joint Pain Injections Sales Forecast by Region (2026-2031) & (K Units)
Table 60. Global Joint Pain Injections Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Joint Pain Injections Sales Forecast by Country (2026-2031) & (K Units)
Table 62. Americas Joint Pain Injections Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Joint Pain Injections Sales Forecast by Region (2026-2031) & (K Units)
Table 64. APAC Joint Pain Injections Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Joint Pain Injections Sales Forecast by Country (2026-2031) & (K Units)
Table 66. Europe Joint Pain Injections Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Joint Pain Injections Sales Forecast by Country (2026-2031) & (K Units)
Table 68. Middle East & Africa Joint Pain Injections Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Joint Pain Injections Sales Forecast by Type (2026-2031) & (K Units)
Table 70. Global Joint Pain Injections Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Joint Pain Injections Sales Forecast by Application (2026-2031) & (K Units)
Table 72. Global Joint Pain Injections Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Allergan Basic Information, Joint Pain Injections Manufacturing Base, Sales Area and Its Competitors
Table 74. Allergan Joint Pain Injections Product Portfolios and Specifications
Table 75. Allergan Joint Pain Injections Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Allergan Main Business
Table 77. Allergan Latest Developments
Table 78. Pfizer Basic Information, Joint Pain Injections Manufacturing Base, Sales Area and Its Competitors
Table 79. Pfizer Joint Pain Injections Product Portfolios and Specifications
Table 80. Pfizer Joint Pain Injections Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Pfizer Main Business
Table 82. Pfizer Latest Developments
Table 83. Sanofi Basic Information, Joint Pain Injections Manufacturing Base, Sales Area and Its Competitors
Table 84. Sanofi Joint Pain Injections Product Portfolios and Specifications
Table 85. Sanofi Joint Pain Injections Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Sanofi Main Business
Table 87. Sanofi Latest Developments
Table 88. Anika Therapeutics Basic Information, Joint Pain Injections Manufacturing Base, Sales Area and Its Competitors
Table 89. Anika Therapeutics Joint Pain Injections Product Portfolios and Specifications
Table 90. Anika Therapeutics Joint Pain Injections Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. Anika Therapeutics Main Business
Table 92. Anika Therapeutics Latest Developments
Table 93. Ferring Basic Information, Joint Pain Injections Manufacturing Base, Sales Area and Its Competitors
Table 94. Ferring Joint Pain Injections Product Portfolios and Specifications
Table 95. Ferring Joint Pain Injections Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Ferring Main Business
Table 97. Ferring Latest Developments
Table 98. Bioventus Basic Information, Joint Pain Injections Manufacturing Base, Sales Area and Its Competitors
Table 99. Bioventus Joint Pain Injections Product Portfolios and Specifications
Table 100. Bioventus Joint Pain Injections Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. Bioventus Main Business
Table 102. Bioventus Latest Developments
Table 103. Flexion Therapeutics Basic Information, Joint Pain Injections Manufacturing Base, Sales Area and Its Competitors
Table 104. Flexion Therapeutics Joint Pain Injections Product Portfolios and Specifications
Table 105. Flexion Therapeutics Joint Pain Injections Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. Flexion Therapeutics Main Business
Table 107. Flexion Therapeutics Latest Developments
Table 108. Zimmer Biomet Holdings Basic Information, Joint Pain Injections Manufacturing Base, Sales Area and Its Competitors
Table 109. Zimmer Biomet Holdings Joint Pain Injections Product Portfolios and Specifications
Table 110. Zimmer Biomet Holdings Joint Pain Injections Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. Zimmer Biomet Holdings Main Business
Table 112. Zimmer Biomet Holdings Latest Developments
Table 113. SEIKAGAKU CORPORATION Basic Information, Joint Pain Injections Manufacturing Base, Sales Area and Its Competitors
Table 114. SEIKAGAKU CORPORATION Joint Pain Injections Product Portfolios and Specifications
Table 115. SEIKAGAKU CORPORATION Joint Pain Injections Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. SEIKAGAKU CORPORATION Main Business
Table 117. SEIKAGAKU CORPORATION Latest Developments
Table 118. Chugai Pharmaceutical Basic Information, Joint Pain Injections Manufacturing Base, Sales Area and Its Competitors
Table 119. Chugai Pharmaceutical Joint Pain Injections Product Portfolios and Specifications
Table 120. Chugai Pharmaceutical Joint Pain Injections Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 121. Chugai Pharmaceutical Main Business
Table 122. Chugai Pharmaceutical Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Joint Pain Injections
Figure 2. Joint Pain Injections Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Joint Pain Injections Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Joint Pain Injections Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Joint Pain Injections Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Joint Pain Injections Sales Market Share by Country/Region (2024)
Figure 10. Joint Pain Injections Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Corticosteroid Injections
Figure 12. Product Picture of Hyaluronic Acid Injections
Figure 13. Product Picture of Others
Figure 14. Global Joint Pain Injections Sales Market Share by Type in 2025
Figure 15. Global Joint Pain Injections Revenue Market Share by Type (2020-2025)
Figure 16. Joint Pain Injections Consumed in Hospital Pharmacies
Figure 17. Global Joint Pain Injections Market: Hospital Pharmacies (2020-2025) & (K Units)
Figure 18. Joint Pain Injections Consumed in Retail Pharmacies
Figure 19. Global Joint Pain Injections Market: Retail Pharmacies (2020-2025) & (K Units)
Figure 20. Joint Pain Injections Consumed in Online Pharmacies
Figure 21. Global Joint Pain Injections Market: Online Pharmacies (2020-2025) & (K Units)
Figure 22. Global Joint Pain Injections Sale Market Share by Application (2024)
Figure 23. Global Joint Pain Injections Revenue Market Share by Application in 2025
Figure 24. Joint Pain Injections Sales by Company in 2025 (K Units)
Figure 25. Global Joint Pain Injections Sales Market Share by Company in 2025
Figure 26. Joint Pain Injections Revenue by Company in 2025 ($ millions)
Figure 27. Global Joint Pain Injections Revenue Market Share by Company in 2025
Figure 28. Global Joint Pain Injections Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Joint Pain Injections Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Joint Pain Injections Sales 2020-2025 (K Units)
Figure 31. Americas Joint Pain Injections Revenue 2020-2025 ($ millions)
Figure 32. APAC Joint Pain Injections Sales 2020-2025 (K Units)
Figure 33. APAC Joint Pain Injections Revenue 2020-2025 ($ millions)
Figure 34. Europe Joint Pain Injections Sales 2020-2025 (K Units)
Figure 35. Europe Joint Pain Injections Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Joint Pain Injections Sales 2020-2025 (K Units)
Figure 37. Middle East & Africa Joint Pain Injections Revenue 2020-2025 ($ millions)
Figure 38. Americas Joint Pain Injections Sales Market Share by Country in 2025
Figure 39. Americas Joint Pain Injections Revenue Market Share by Country (2020-2025)
Figure 40. Americas Joint Pain Injections Sales Market Share by Type (2020-2025)
Figure 41. Americas Joint Pain Injections Sales Market Share by Application (2020-2025)
Figure 42. United States Joint Pain Injections Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Joint Pain Injections Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Joint Pain Injections Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Joint Pain Injections Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Joint Pain Injections Sales Market Share by Region in 2025
Figure 47. APAC Joint Pain Injections Revenue Market Share by Region (2020-2025)
Figure 48. APAC Joint Pain Injections Sales Market Share by Type (2020-2025)
Figure 49. APAC Joint Pain Injections Sales Market Share by Application (2020-2025)
Figure 50. China Joint Pain Injections Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Joint Pain Injections Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Joint Pain Injections Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Joint Pain Injections Revenue Growth 2020-2025 ($ millions)
Figure 54. India Joint Pain Injections Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Joint Pain Injections Revenue Growth 2020-2025 ($ millions)
Figure 56. China Taiwan Joint Pain Injections Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Joint Pain Injections Sales Market Share by Country in 2025
Figure 58. Europe Joint Pain Injections Revenue Market Share by Country (2020-2025)
Figure 59. Europe Joint Pain Injections Sales Market Share by Type (2020-2025)
Figure 60. Europe Joint Pain Injections Sales Market Share by Application (2020-2025)
Figure 61. Germany Joint Pain Injections Revenue Growth 2020-2025 ($ millions)
Figure 62. France Joint Pain Injections Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Joint Pain Injections Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Joint Pain Injections Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Joint Pain Injections Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Joint Pain Injections Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Joint Pain Injections Sales Market Share by Type (2020-2025)
Figure 68. Middle East & Africa Joint Pain Injections Sales Market Share by Application (2020-2025)
Figure 69. Egypt Joint Pain Injections Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Joint Pain Injections Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Joint Pain Injections Revenue Growth 2020-2025 ($ millions)
Figure 72. Turkey Joint Pain Injections Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Joint Pain Injections Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Joint Pain Injections in 2025
Figure 75. Manufacturing Process Analysis of Joint Pain Injections
Figure 76. Industry Chain Structure of Joint Pain Injections
Figure 77. Channels of Distribution
Figure 78. Global Joint Pain Injections Sales Market Forecast by Region (2026-2031)
Figure 79. Global Joint Pain Injections Revenue Market Share Forecast by Region (2026-2031)
Figure 80. Global Joint Pain Injections Sales Market Share Forecast by Type (2026-2031)
Figure 81. Global Joint Pain Injections Revenue Market Share Forecast by Type (2026-2031)
Figure 82. Global Joint Pain Injections Sales Market Share Forecast by Application (2026-2031)
Figure 83. Global Joint Pain Injections Revenue Market Share Forecast by Application (2026-2031)